Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of Semtech Corporation, urging shareholders to take action promptly due to possible time limitations on enforcing their rights [2]. Group 1: Shareholder Rights and Options - Shareholders of Semtech Corporation may seek corporate governance reforms, financial incentives, or other benefits if they are long-term investors [3]. - The firm emphasizes that shareholder involvement is crucial for improving company policies and enhancing shareholder value through better management and accountability [4]. Group 2: Legal Representation and Support - Halper Sadeh LLC represents global investors affected by securities fraud and corporate misconduct, having successfully recovered millions for defrauded investors [5]. - The firm operates on a contingent fee basis, meaning shareholders will not incur out-of-pocket legal fees [1].

Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of ASP Isotopes Inc. (NASDAQ: ASPI) towards shareholders [1] Group 1: Investigation Details - The investigation focuses on whether the actions of ASP Isotopes Inc. insiders have harmed shareholder interests [1] - Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation [1] Group 2: Shareholder Rights and Options - Long-term shareholders of ASP Isotopes may seek corporate governance reforms, return of funds, court-approved financial incentives, or other relief [1] - Participation of shareholders is emphasized as a means to improve company policies and enhance shareholder value [1] Group 3: Legal Representation - Halper Sadeh LLC represents investors globally who have experienced securities fraud and corporate misconduct, recovering millions for defrauded investors [1]

Core Viewpoint - Bleichmar Fonti & Auld LLP is investigating Reservoir Media, Inc. and its significant shareholders for potential breaches of fiduciary duties related to a proposed take-private sale at $10.50 per share, which may be considered unfair to minority shareholders [1][5]. Group 1: Investigation Details - The investigation focuses on the board of directors of Reservoir Media, along with major shareholders Wesbild, Inc. and ER Reservoir LLC, regarding their fiduciary responsibilities to minority shareholders [1][5]. - On March 4, 2026, ER Reservoir LLC and Wesbild Inc. submitted a preliminary non-binding proposal to acquire all outstanding shares of Reservoir Media at a price of $10.50 per share [3][5]. - ER Reservoir LLC and Wesbild Inc. collectively own 65% of Reservoir Media's stock, which allows them to control the outcome of shareholder votes requiring majority approval [4]. Group 2: Shareholder Implications - The proposed acquisition price of $10.50 per share is under scrutiny to determine if it is unfairly low, potentially breaching fiduciary duties owed to minority shareholders [5]. - Current shareholders of Reservoir Media are encouraged to seek additional information and may have legal options available to them [2][6].

Core Viewpoint - Reservoir Media, Inc. is under investigation for potential breaches of fiduciary duties by its board and major shareholders in relation to a proposed take-private deal at $10.50 per share, which may be considered an unfairly low price for minority shareholders [1]. Group 1: Investigation Details - Bleichmar Fonti & Auld LLP is investigating Reservoir Media's board of directors and significant shareholders Wesbild, Inc. and ER Reservoir LLC regarding the proposed take-private sale [1]. - The proposed acquisition price of $10.50 per share was announced on March 4, 2026, by ER Reservoir LLC and Wesbild Inc., who collectively own 65% of Reservoir Media's stock [1]. - The investigation aims to determine if the proposed price is unfairly low and if the board and controlling shareholders are breaching their fiduciary duties to minority stockholders [1]. Group 2: Shareholder Actions - Current shareholders of Reservoir Media are encouraged to seek additional information and may have legal options available to them [1]. - The law firm operates on a contingency fee basis, meaning shareholders will not incur costs for court expenses or litigation [1]. - Shareholders can submit their information to the firm for potential representation [1].

Core Viewpoint - Grabar Law Office is investigating claims on behalf of shareholders of Molina Healthcare, Inc. regarding potential breaches of fiduciary duties by certain officers and directors of the company [1]. Group 1: Investigation Details - The investigation is focused on whether Molina Healthcare's officers and directors failed to disclose material adverse facts related to the company's financial health, specifically concerning "medical cost trend assumptions" and a "dislocation between premium rates and medical cost" [3]. - Allegations include that Molina Healthcare's near-term growth relied on a lack of utilization of various health services, which could lead to a significant reduction in the company's financial guidance for fiscal year 2025 [3]. Group 2: Shareholder Actions - Shareholders who purchased Molina Healthcare shares prior to February 5, 2025, and still hold them can seek corporate reforms, the return of funds to the company, and a court-approved incentive award at no cost [2][4]. - Interested shareholders are encouraged to contact Grabar Law Office for more information on how to proceed with their claims [2][4]. Group 3: Law Firm Background - Grabar Law Office is recognized for its extensive experience in complex commercial litigation, particularly in securities class actions and individual shareholder litigation under federal and state laws [5]. - The firm has a strong reputation, with its lawyers rated for high levels of professional excellence and ethical standing [5].

Core Viewpoint - Grabar Law Office is investigating claims on behalf of shareholders of Molina Healthcare, Inc. regarding potential breaches of fiduciary duties by certain officers and directors [1] Group 1: Investigation Details - The investigation is focused on whether Molina Healthcare's officers and directors failed to disclose material adverse facts related to the company's financial health [3] - Allegations include undisclosed issues with medical cost trend assumptions and a dislocation between premium rates and medical costs, which could lead to a significant cut in financial guidance for fiscal year 2025 [3] Group 2: Shareholder Actions - Shareholders who purchased Molina Healthcare shares prior to February 5, 2025, and still hold them can seek corporate reforms and the return of funds at no cost [2][4] - Interested shareholders are encouraged to contact Grabar Law Office for more information on the investigation and potential actions [2][4] Group 3: Grabar Law Office Background - Grabar Law Office is recognized for its expertise in complex commercial litigation, particularly in securities class actions and shareholder litigation [5] - The firm has a strong reputation, with attorneys rated for high professional excellence and ethical standing [5]

Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of B. Riley Financial, Inc. (NASDAQ: RILY) towards shareholders [1] Group 1 - The investigation may provide long-term shareholders of RILY stock the opportunity to seek corporate governance reforms [1] - Shareholders may also pursue the return of funds back to the company as part of the investigation [1] - There is a possibility for court-approved financial incentive awards or other relief and benefits for shareholders [1]

Core Viewpoint - Grabar Law Office is investigating claims against Integer Holdings, Corp. regarding potential breaches of fiduciary duties by certain officers and directors [1][3]. Group 1: Investigation Details - The investigation focuses on whether officers and directors of Integer Holdings, Corp. breached their fiduciary duties to the company [1]. - Shareholders who purchased shares prior to July 25, 2024, and still hold them can seek corporate reforms and the return of funds at no cost [2][4]. Group 2: Allegations of Misconduct - A federal securities fraud class action complaint alleges that Integer Holdings made materially false and misleading statements about its business and operations [3]. - Specific allegations include: 1. Integer overstated its competitive position in the EP manufacturing market [3]. 2. The company experienced a deterioration in sales for two of its EP devices, contrary to claims of strong customer demand [3]. 3. Integer mischaracterized its EP devices as long-term growth drivers for its C&V segment [3]. 4. Positive statements made by the defendants about the company's prospects were materially false and lacked a reasonable basis [3].

Core Viewpoint - Kuehn Law is investigating potential breaches of fiduciary duties by officers and directors of DeFi Technologies Inc. (NASDAQ: DEFT) towards shareholders [1] Group 1: Legal Investigation - A federal securities lawsuit alleges that insiders at DeFi misrepresented or failed to disclose critical information regarding delays in executing its DeFi arbitrage strategy, which is a key revenue driver [2] - The lawsuit claims that DeFi understated the competition it faced from other DAT companies and the negative impact this competition would have on its business [2] - As a result of these issues, DeFi is unlikely to meet its previously issued revenue guidance, and the true extent of the negative impact on its financial results was downplayed [2] Group 2: Shareholder Action - Shareholders who purchased DEFT prior to May 12, 2025, are encouraged to contact Kuehn Law for potential legal action, as there may be limited time to enforce their rights [3] - Kuehn Law covers all case costs and does not charge its investor clients, emphasizing the importance of shareholder involvement in maintaining market integrity [4]

Core Viewpoint - Grabar Law Office is investigating claims on behalf of shareholders of Lantheus Holdings, Inc. regarding potential breaches of fiduciary duties by certain officers and directors [1]. Group 1: Investigation Details - The investigation focuses on whether Lantheus Holdings' officers and directors made false statements or concealed information about the company's revenue outlook and growth potential [3]. - Allegations include that the company misrepresented its understanding of market dynamics, particularly regarding the sales growth potential and pricing of its product Pylarify [3]. Group 2: Shareholder Actions - Shareholders who purchased Lantheus Holdings shares prior to November 6, 2024, and still hold them can seek corporate reforms and the return of funds to the company at no cost [2][4]. - Interested shareholders are encouraged to contact Grabar Law Office for more information on the investigation and potential actions [2][4].